The pharmacological management of violence in schizophrenia: a structured review

  title={The pharmacological management of violence in schizophrenia: a structured review},
  author={Anya Topiwala and Seena Fazel},
  journal={Expert Review of Neurotherapeutics},
  pages={53 - 63}
  • A. TopiwalaS. Fazel
  • Published 1 January 2011
  • Psychology, Medicine
  • Expert Review of Neurotherapeutics
Although the increased risk of violent behavior in individuals with schizophrenia is now well-established, there is considerable uncertainty in pharmacological strategies to reduce this risk. In this review, we performed a systematic search of three electronic databases from January 2000 to March 2010 of treatment research on the management of violence in schizophrenia. We identified eight randomized controlled trials. The main findings included the association of nonadherence to antipsychotic… 

Preventing Violence in Patients with Schizophrenia

A specific antiaggressive effect of clozapine has been identified and should be considered as a treatment option for persons with schizophrenia and persistent aggressive behavior and a potential alternative is olanzapine, based on a randomized controlled trial.

Cognition and Other Targets for the Treatment of Aggression in People with Schizophrenia

The etiological heterogeneity of aggression in schizophrenia calls for the development of a comprehensive treatment program that targets several contributors to aggression, and the authors recommend studies into the possible anti-aggressive benefits of treatments that target these factors.

A systematic review of the evidence of clozapine's anti-aggressive effects.

Reducing the risk of violent and aggressive behaviour in patients with schizophrenia remains a clinical priority. There is emerging evidence to suggest that the second-generation antipsychotic,

Violence prevention in psychiatry: an umbrella review of interventions in general and forensic psychiatry

The lack of intervention research in violence prevention in general and forensic psychiatry suggests that interventions from non-psychiatric populations may need to be relied upon.

Pathways to aggression in schizophrenia affect results of treatment.

Schizophrenia elevates the risk for aggressive behavior and violent crime, and different approaches have been used to manage this problem. The results of such treatments vary. One reason for this

Aggression in Psychoses

Nonpharmacological methods of treatment of aggression in schizophrenia and bipolar disorder are increasingly important and Cognitive behavioral approaches appear to be effective in cases where pharmacotherapy alone is not sufficient.

Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy

The hypothesized neurobiological substrates of various types of violence and aggression are discussed, as well as providing arguments for the use of antipsychotic polypharmacy and high-dose monotherapy to target dysfunctional neurocircuitry in the subpopulation of patients that is treatment-resistant, violent, and aggressive.

Pharmacological management of persistent hostility and aggression in persons with schizophrenia spectrum disorders: a systematic review.

Paliperidone-extended release currently appears to be the agent for the management of hostility among inpatients with SSDs for which there is the strongest evidence of efficacy.

Violence in schizophrenia and bipolar disorder.

  • J. Volavka
  • Psychology, Medicine
    Psychiatria Danubina
  • 2013
BACKGROUND Although most psychiatric patients are not violent, serious mental illness is associated with increased risk of violent behavior. Most of the evidence available pertains to schizophrenia



Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia

Effective antipsychotics are needed, but may not reduce violence unrelated to acute psychopathology, but not in patients with a history of childhood antisocial conduct.

Heterogeneity of violence in schizophrenia and implications for long‐term treatment

The aim of this review is to address the subtyping of violent behaviour in schizophrenia, and to relate the subtypes to treatment.

Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment.

Treatment with atypical antipsychotic medications should be considered as an important component of violence risk management for schizophrenia patients at risk for violent behavior.

A national study of violent behavior in persons with schizophrenia.

To examine the prevalence and correlates of violence among schizophrenia patients living in the community by developing multivariable statistical models to assess the net effects of psychotic symptoms and other risk factors for minor and serious violence, a large number of patients diagnosed as having schizophrenia were enrolled.

Violence in inpatients with schizophrenia: a prospective study.

This study is the first to demonstrate that insight into psychotic symptoms is a predictor of violence in inpatients with schizophrenia.

Insight into illness and adherence to psychotropic medications are separately associated with violence severity in a forensic sample.

Overall, medication non-adherence explained a large amount of how violently participants behaved toward others, and treatment addressing medication adherence needs to concomitantly target substance use behaviors since the latter was responsible for a substantial increase in ODV.

The effect of lithium on impulsive aggressive behavior in man.

It is suggested that lithium can have a clinically useful effect upon impulsive aggressive behavior when this behavior is not associated with psychosis.

The effect of quetiapine on aggression and hostility in patients with schizophrenia

Quetiapine may be a suitable option for patients with schizophrenia and aggressive behaviour and was highly correlated with improvements in positive symptoms and there was no consistent relationship between sedation and hostility.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Clozapine shows greater efficacy than olanZapine and olanzapine great efficacy than haloperidol in reducing aggressive behavior and this antiaggressive effect appears to be separate from the antipsychotic and sedative action of these medications.

Violent behavior in mental illness: the role of substance abuse.

Emerging evidence suggests that irrespective of comorbidity with substance abuse disorder, at least 2 alternative pathways to violence may occur in patients with schizophrenia: one pathway that is associated with a history of long-standing antisocial behavior problems typically beginning in childhood and another pathway without such history.